Bsenexus Terminal Open Filings terminal →
Material event BSE: 532331

Ajanta Pharma Ltd

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2026 for Aayush Agrawal, ....